Nuclear Magnetic Resonance Spectroscopy (MRS) in the study of human renal neoplastic pathologies has two types of applications: - The first application is aimed at the clinical use of in vivo spectroscopy as it is commonly employed for other organs, such as brain, prostate and breast (diagnosis, treatment and control, prognosis); - The second one is due to its ability to identify tissue metabolites. This specificity allows the control of molecular changes, i.e. altered metabolic processes, taking place in renal neoplastic tissues. Thus, it makes a contribution, at molecular level, to the knowledge of tumor biochemistry. From this point of view, MRS is aimed at either clinical or basic research. For these reasons the chapter is organized according to the research advancements both at biochemical and clinical level.
V. Tugnoli, M.R. Tosi (2005). Current status of Magnetic Resonance Spectroscopy in the study of kidney tumors.. NEW YORK : Nova Science Publishers, Inc..
Current status of Magnetic Resonance Spectroscopy in the study of kidney tumors.
TUGNOLI, VITALIANO;
2005
Abstract
Nuclear Magnetic Resonance Spectroscopy (MRS) in the study of human renal neoplastic pathologies has two types of applications: - The first application is aimed at the clinical use of in vivo spectroscopy as it is commonly employed for other organs, such as brain, prostate and breast (diagnosis, treatment and control, prognosis); - The second one is due to its ability to identify tissue metabolites. This specificity allows the control of molecular changes, i.e. altered metabolic processes, taking place in renal neoplastic tissues. Thus, it makes a contribution, at molecular level, to the knowledge of tumor biochemistry. From this point of view, MRS is aimed at either clinical or basic research. For these reasons the chapter is organized according to the research advancements both at biochemical and clinical level.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
